The big trend in liquid chromatography instrumentation is the ever-shrinking sample size, according to leading manufacturers of chromatographic instruments. [ + ]

In a much-needed show of investor support, cardboard king Richard Pratt has become a substantial shareholder of Amrad Corporation. [ + ]

Adelaide growth factor biobusiness GroPep has laid out its path to profits by announcing plans to concentrate on growing its pharmaceutical cell culture division. [ + ]

Nominations are now open for the Australian Academy of Science's Awards for Scientific Excellence and Grants for International Travel.

Australian cookbook icon Margaret Fulton joined Greenpeace at Sydney's Fox Studios on Friday last week to launch the environmental campaigner's True Food Guide book. [ + ]

Australia's decision to back stem cell research with a $46.5 million grant would have international ramifications for local researchers, according to the head of the winning Centre of Excellence bid. [ + ]

Sydney-based company Proteome Systems' proteomics R&D system, ProteomIQ, has been launched on the market. [ + ]

A New Zealand representative is to join the Australian Synchrotron Project's scientific advisory committee, cementing a trans-Tasman link between users of the new facility. [ + ]

New Zealand's political leadership is declaring the Land of the Long White Cloud open for collaborative ventures with Australia's biotech sector. [ + ]

The chief executive officer and three other directors have resigned from Bio21 following a restructure that has seen the company abandon its commercial focus. [ + ]

Researchers at the Walter and Eliza Hall Institute have discovered that treatment with cytokine Leukaemia Inhibitory Factor (LIF) can reverse the loss of nerve cells in a mouse model of multiple sclerosis (MS). [ + ]

The 2nd Australian Microarray Meeting is to be held at Couran Cove Resort, Sth Stradbroke Island from July 24th to 26th 2002. The meeting will focus on show casing recent national and international advances in expression profiling and other microarray technologies.

Opponents of stem cell research taking part in consultative processes on draft legislation were shocked and surprised by the announcement that the Stem Cells and Tissue Repair consortium had won the Federal government's $46.5 million Centre of Excellence funding. [ + ]

Troubled biopharmaceutical group Vita Life Sciences has warned shareholders not to expect much from the natural medicines arm of its business in the coming year. [ + ]

A new clinical diagnostic assay for prostate cancer detection is starting clinical trials at St Vincent's Clinic in Sydney. [ + ]